Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin glargine |
Is a |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Protamine zinc insulin |
Is a |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Extended zinc insulin |
Is a |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin glargine (substance) |
Is a |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline zinc en suspension (humaine), 100 unités/mL, flacon de 10 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin zinc crystalline human suspension 100units/mL injection vial (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline-protamine-zinc bovine, 100 unités/mL, flacon de 10 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing long-acting insulin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin zinc suspension bovine 100u/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin zinc suspension bovine and porcine 100units/mL injection 10mL vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin detemir |
Is a |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin zinc suspension extended human 100units/mL injection suspension 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Long-acting insulin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|